Prophylactic versus preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

被引：0
|
作者：
Arcuri, Leonardo Javier [1 ]
机构：
[1] Hosp Israelita Albert Einstein, Acad Res Org, Sao Paulo, Brazil
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 03期
关键词：
D O I：
10.1038/s41409-023-02186-y
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：435 / 436
页数：2
相关论文
共 50 条
  • [41] Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Guillaume, Thierry
    Yakoub-Agha, Ibrahim
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Magro, Leonardo
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Mohty, Mohamad
    BLOOD, 2016, 128 (22)
  • [42] Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome
    Guillaume, Thierry
    Thepot, Sylvain
    Peterlin, Pierre
    Ceballos, Patrice
    Le Bourgeois, Amandine
    Garnier, Alice
    Orvain, Corentin
    Giltat, Aurelien
    Francois, Sylvie
    Le Bris, Yannick
    Fronteau, Clementine
    Planche, Lucie
    Chevallier, Patrice
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 839.e1 - 839.e6
  • [43] Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation
    Lu, Wenyi
    Zhang, Meng
    Lv, Hairong
    Xiao, Xia
    Bai, Xue
    Wang, Jiaxi
    Pu, Yedi
    Meng, Juanxia
    Zhang, Xiaomei
    Zhu, Haibo
    Yuan, Ting
    Wang, Bing
    Jin, Xin
    Cao, Xinping
    Wang, Zhao
    Xie, Tianle
    Meng, Haotian
    Stepanov, Alexey
    Gabibov, Alexander G.
    An, Yuxin
    Sun, Rui
    Zhang, Yu
    Maschan, Mikhail A.
    Zhu, Zunmin
    Zhang, Hongkai
    Zhao, Mingfeng
    BLOOD, 2023, 142
  • [44] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Thierry Guillaume
    Florent Malard
    Leonardo Magro
    Myriam Labopin
    Reza Tabrizi
    Cécile Borel
    Patrice Chevallier
    Stéphane Vigouroux
    Pierre Peterlin
    Alice Garnier
    Marie-Thérèse Rubio
    Anne Huynh
    Noël Milpied
    Philippe Moreau
    Béatrice Gaugler
    Ibrahim Yakoub-Agha
    Mohamad Mohty
    Bone Marrow Transplantation, 2019, 54 : 1815 - 1826
  • [45] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Guillaume, Thierry
    Malard, Florent
    Magro, Leonardo
    Labopin, Myriam
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Gaugler, Beatrice
    Yakoub-Agha, Ibrahim
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2019, 54 (11) : 1815 - 1826
  • [46] Outcome of Donor Lymphocyte Infusion after T Cell-depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
    Krishnamurthy, Pramila
    Potter, Victoria T.
    Barber, Linda D.
    Kulasekararaj, Austin G.
    Lim, Zi Yi
    Pearce, Rachel M.
    de Lavallade, Hugues
    Kenyon, Michelle
    Ireland, Robin M.
    Marsh, Judith C. W.
    Devereux, Stephen
    Pagliuca, Antonio
    Mufti, Ghulam J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) : 562 - 568
  • [47] Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
    Mengarelli, A
    Iori, A
    Guglielmi, C
    Romano, A
    Cerretti, R
    Torromeo, C
    Micozzi, A
    Fenu, S
    Laurenti, L
    Donato, V
    De Felice, L
    Arcese, W
    HAEMATOLOGICA, 2002, 87 (01) : 52 - 58
  • [48] Donor lymphocyte infusions in patients with leukemia after allogeneic hematopoietic stem cell transplantation.
    Liu, QF
    Sun, J
    Liu, YL
    Zhou, SY
    BLOOD, 2002, 100 (11) : 448B - 448B
  • [49] Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
    Yan, Chen-Hua
    Liu, Dai-Hong
    Liu, Kai-Yan
    Xu, Lan-Ping
    Liu, Yan-Rong
    Chen, Huan
    Han, Wei
    Wang, Yu
    Qin, Ya-Zhen
    Huang, Xiao-Jun
    BLOOD, 2012, 119 (14) : 3256 - 3262
  • [50] Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
    van der Zouwen, Boris
    Koster, E. A. S.
    von dem Borne, P. A.
    Oosten, L. E. M.
    Roza-Scholten, M. W. I.
    Snijders, T. J. F.
    van Lammeren, D.
    van Balen, P.
    Marijt, W. A. F.
    Veelken, H.
    Falkenburg, J. H. F.
    de Wreede, L. C.
    Halkes, C. J. M.
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1203 - 1213
12345